New research enhances the current knowledge of how human immunodeficiency virus type-1 (HIV-1), which causes AIDS, controls the cell cycle of cells that it infects. The new findings may shed light on how the virus reactivates after entering a dorman…
Researchers at the University of Minnesota Academic Health Center have identified two drugs that, when combined, may serve as an effective treatment for HIV.
The two drugs, decitabine and gemcitabine — both FDA approved and currently used in pre…
Virologists at Jefferson Medical College may have discovered a new way by which HIV, the AIDS virus, can evade both anti-viral drugs and vaccines. Researchers had reported last summer that a protein called CEM15 is a natural inhibitor of HIV, acting as a brake on HIV’s replication. They also showed that an HIV-encoded protein, Vif, or Virion infectivity factor, counteracts CEM15. Vif, in effect, is a shield to protect HIV from a host cell’s defenses.
A new study from Johns Hopkins researchers shows the multiple anti-HIV drug regimen called highly active antiretroviral therapy (HAART) saves eyesight as well as lives. A second study led by Johns Hopkins researchers finds that among AIDS patients with longstanding vision problems, those who took HAART reported higher overall quality of life.